Skip to main content

Table 3 Results of the univariate regression models

From: Perioperative factors associated with survival following surgery for pancreatic cancer – a nationwide analysis of 473 cases from Denmark.

Category

Variable

Sub variable

Hazard Ratio

95% Confidence Interval

p-value

Demographic

Sex

Female

1.08

0.85–1.36

0.549

 

Age

 

1.02

1.00-1.03

0.010

 

ASA score

 

1.39

1.11–1.73

0.004

 

Body mass index

 

0.98

0.95–1.01

0.254

 

Charlson Comorbidity index

 

1.18

1.06–1.18

7.26 × 10− 5

 

Smoking

Current smoker

0.96

0.73–1.25

0.758

 

Alcohol

1–21 drinks/week

0.72

0.35–1.48

0.369

  

> 21 drinks/week

0.73

0.53–0.99

0.046

Perioperative

Procedure time

 

0.99

0.99–0.99

0.013

 

Epidural analgesia

 

0.76

0.58–0.99

0.045

 

Type of anesthesia§

Intravenous and inhalation

0.64

0.50–0.82

0.002

 

Perioperative blood transfusion

 

1.69

0.45–0.79

3.55 × 10− 4

Tumor related

Preoperative chemotherapy

 

0.88

0.57–1.35

0.564

 

Postoperative chemotherapy

 

0.58

0.44–0.76

3.00 × 10− 4

 

Type of resection*

Total Pancreatectomy, TP

1.21

0.79–1.86

0.584

  

Pancreaticoduodenectomy, PD

1.28

0.54–2.99

0.575

 

Tumor T stage#

T2

4.23

1.66–10.78

0.003

  

T3

4.08

1.97–11.70

0.001

  

T4

3.11

0.90-10.75

0.083

 

Tumor N stage**

N1

2.23

1.58–3.16

6.11 × 10− 6

  

N2

2.09

1.26–3.47

0.004

 

Resection margin

R1

1.44

1.08–1.92

0.014

  1. Note: §Total intravenous anesthesia (TIVA) used as reference.
  2. * Distal Pancreatectomy used as reference.
  3. #T1 tumor stage used as reference.
  4. ** N0 tumor stage used as reference.